Prelude Capital Management’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $261K | Buy |
265,588
+97,283
| +58% | +$95.8K | 0.03% | 670 |
|
|
2025
Q1 | $242K | Buy |
168,305
+48,630
| +41% | +$70K | 0.02% | 730 |
|
|
2024
Q4 | $263K | Sell |
119,675
-123,172
| -51% | -$271K | 0.02% | 744 |
|
|
2024
Q3 | $401K | Sell |
242,847
-28,042
| -10% | -$46.3K | 0.02% | 641 |
|
|
2024
Q2 | $601K | Buy |
270,889
+242,926
| +869% | +$539K | 0.04% | 406 |
|
|
2024
Q1 | $74.9K | Sell |
27,963
-1,828
| -6% | -$4.9K | ﹤0.01% | 1114 |
|
|
2023
Q4 | $89.1K | Buy |
+29,791
| New | +$89.1K | 0.01% | 906 |
|
|
2018
Q1 | – | Sell |
-500
| Closed | -$33K | – | 1401 |
|
|
2017
Q4 | $33K | Buy |
500
+400
| +400% | +$26.4K | ﹤0.01% | 903 |
|
|
2017
Q3 | $5K | Sell |
100
-100
| -50% | -$5K | ﹤0.01% | 1372 |
|
|
2017
Q2 | $9K | Buy |
+200
| New | +$9K | ﹤0.01% | 1288 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 1432 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 1466 |
|